Back | Next |
home / stock / addxf / addxf message board
Subject | By | Source | When |
---|---|---|---|
Article about PD-related diskinesia and mGluR5 from the MJFF: | tykundegex | investorshub | 10/11/2012 8:25:25 AM |
Misc analyst quotes about Addex on The Life | tykundegex | investorshub | 10/03/2012 11:41:32 AM |
Sorry, that woule be August 2013. | tykundegex | investorshub | 08/02/2012 10:36:01 AM |
Addex Partner to Initiate Phase 2 Clinical Trial | tykundegex | investorshub | 06/05/2012 10:18:51 AM |
Up 92% in Zurich today. But | tykundegex | investorshub | 03/22/2012 12:35:17 PM |
This company has blockbuster potential folks -- a | tykundegex | investorshub | 03/22/2012 9:08:47 AM |
Awesome news!!! Addex Reports Positive Top Line | tykundegex | investorshub | 03/21/2012 5:44:38 PM |
Addex changes name to Addex Therapeutics | tykundegex | investorshub | 03/21/2012 9:04:18 AM |
Previously confidential but newly published white paper on | tykundegex | investorshub | 03/15/2012 10:03:13 AM |
Coverage by Ladenburg Thalmann: BUY with target price | tykundegex | investorshub | 03/07/2012 6:12:10 PM |
2012 Addex Corporate Presentation | tykundegex | investorshub | 01/10/2012 11:18:05 AM |
Great overview of the company - $CEO presenstaion | tykundegex | investorshub | 10/21/2011 3:47:28 PM |
Article from Sep 5: | tykundegex | investorshub | 10/04/2011 3:14:52 PM |
Addex to Present Progress on Multiple Allosteric Modulator | tykundegex | investorshub | 10/04/2011 7:55:40 AM |
Maybe, since the new CEO has an entirely | tykundegex | investorshub | 09/05/2011 8:33:49 AM |
News: Addex Regains Rights to Parkinsons Drug Candidates | tykundegex | investorshub | 09/05/2011 8:32:30 AM |
Looks like the CEO was granted rights/options representing | tykundegex | investorshub | 08/22/2011 7:20:29 AM |
Corporate Presentation from Aug 5 | tykundegex | investorshub | 08/19/2011 10:15:55 AM |
Insider: Buying by a executive director / management: | tykundegex | investorshub | 08/19/2011 10:08:11 AM |
New Edison report out (after CEO hire): | tykundegex | investorshub | 08/17/2011 10:20:35 AM |
News, Short Squeeze, Breakout and More Instantly...
Addex Pharms Ltd Ord Company Name:
ADDXF Stock Symbol:
OTCMKTS Market:
Geneva, Switzerland, May 8, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will present at the Bio€quity Europe 2024 conference taking place May...
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 29, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, t...
Geneva, Switzerland, April 19, 2024 - Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug development, announced today that CEO, Tim Dyer, will present at the Swiss Biotech Day 2024 conference taking place April ...